RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
The objective of the study is to determine the safety and tolerability of RG2133 in patients
 with Mitochondrial Disease.
Mitochondrial Disease